136 related articles for article (PubMed ID: 16650230)
1. Growth, bone mineral accretion, and adrenal function in glucocorticoid-treated infants with hemangiomas-- a retrospective study.
Lomenick JP; Backeljauw PF; Lucky AW
Pediatr Dermatol; 2006; 23(2):169-74. PubMed ID: 16650230
[TBL] [Abstract][Full Text] [Related]
2. Adverse effects of systemic glucocorticosteroid therapy in infants with hemangiomas.
George ME; Sharma V; Jacobson J; Simon S; Nopper AJ
Arch Dermatol; 2004 Aug; 140(8):963-9. PubMed ID: 15313812
[TBL] [Abstract][Full Text] [Related]
3. Monitoring growth in asthmatic children treated with high dose inhaled glucocorticoids does not predict adrenal suppression.
Dunlop KA; Carson DJ; Steen HJ; McGovern V; McNaboe J; Shields MD
Arch Dis Child; 2004 Aug; 89(8):713-6. PubMed ID: 15269067
[TBL] [Abstract][Full Text] [Related]
4. Intralesional corticosteroid therapy in hemangiomas: clinical outcome in 160 cases.
Chantharatanapiboon W
J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S90-6. PubMed ID: 19253502
[TBL] [Abstract][Full Text] [Related]
5. Impaired adrenal function after glucocorticoid therapy in children with acute lymphoblastic leukemia.
Petersen KB; Müller J; Rasmussen M; Schmiegelow K
Med Pediatr Oncol; 2003 Aug; 41(2):110-4. PubMed ID: 12825213
[TBL] [Abstract][Full Text] [Related]
6. A review of the effects of therapy on growth and bone mineralization in children with congenital adrenal hyperplasia.
Gallagher MP; Levine LS; Oberfield SE
Growth Horm IGF Res; 2005 Jul; 15 Suppl A():S26-30. PubMed ID: 16039891
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppressive effects in infants treated with corticosteroids for infantile hemangiomas.
Kelly ME; Juern AM; Grossman WJ; Schauer DW; Drolet BA
Arch Dermatol; 2010 Jul; 146(7):767-74. PubMed ID: 20479291
[TBL] [Abstract][Full Text] [Related]
8. Adrenal suppression and osteoporosis after treatment of nasal polyposis.
Bonfils P; Halimi P; Malinvaud D
Acta Otolaryngol; 2006 Dec; 126(11):1195-200. PubMed ID: 17050313
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of adrenal insufficiency following systemic glucocorticoid therapy in infants with hemangiomas.
Lomenick JP; Reifschneider KL; Lucky AW; Adams D; Azizkhan RG; Woo JG; Backeljauw PF
Arch Dermatol; 2009 Mar; 145(3):262-6. PubMed ID: 19289754
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.
De Nijs RN
Minerva Med; 2008 Feb; 99(1):23-43. PubMed ID: 18299694
[TBL] [Abstract][Full Text] [Related]
11. Oral versus high-dose pulse corticosteroids for problematic infantile hemangiomas: a randomized, controlled trial.
Pope E; Krafchik BR; Macarthur C; Stempak D; Stephens D; Weinstein M; Ho N; Baruchel S
Pediatrics; 2007 Jun; 119(6):e1239-47. PubMed ID: 17485449
[TBL] [Abstract][Full Text] [Related]
12. [Vincristine treatment for function- and life-threatening infantile hemangioma].
Enjolras O; Brevière GM; Roger G; Tovi M; Pellegrino B; Varotti E; Soupre V; Picard A; Leverger G
Arch Pediatr; 2004 Feb; 11(2):99-107. PubMed ID: 14761730
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of evaluation and treatment of glucocorticoid-induced osteoporosis in men.
Cruse LM; Valeriano J; Vasey FB; Carter JD
J Clin Rheumatol; 2006 Oct; 12(5):221-5. PubMed ID: 17023807
[TBL] [Abstract][Full Text] [Related]
14. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia].
Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M
Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849
[TBL] [Abstract][Full Text] [Related]
15. Suppression and recovery of the hypothalamic function after high-dose corticosteroid treatment in preterm infants.
Ng PC; Lam CW; Lee CH; Chan IH; Wong SP; Fok TF
Neonatology; 2008; 94(3):170-5. PubMed ID: 18612214
[TBL] [Abstract][Full Text] [Related]
16. [Relationship between bone mineral content and growth disorders in children with juvenile idiopathic arthritis].
Górska A; Urban M; Konstantynowicz J; Bartnicka M; Chlabicz S; Górski S; Kaczmarski M
Pol Merkur Lekarski; 2008 Mar; 24(141):227-30. PubMed ID: 18634288
[TBL] [Abstract][Full Text] [Related]
17. Adrenal axis function after high-dose steroid therapy for childhood acute lymphoblastic leukemia.
Einaudi S; Bertorello N; Masera N; Farinasso L; Barisone E; Rizzari C; Corrias A; Villa A; Riva F; Saracco P; Pastore G
Pediatr Blood Cancer; 2008 Mar; 50(3):537-41. PubMed ID: 17828747
[TBL] [Abstract][Full Text] [Related]
18. Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trial.
Willemsen RH; Arends NJ; Bakker-van Waarde WM; Jansen M; van Mil EG; Mulder J; Odink RJ; Reeser M; Rongen-Westerlaken C; Stokvis-Brantsma WH; Waelkens JJ; Hokken-Koelega AC
Clin Endocrinol (Oxf); 2007 Oct; 67(4):485-92. PubMed ID: 17561977
[TBL] [Abstract][Full Text] [Related]
19. [Glucocorticoid treatments and adrenal function].
Guignat L; de Bucy C; Bertherat J
Rev Prat; 2008 May; 58(9):966-70. PubMed ID: 18672662
[TBL] [Abstract][Full Text] [Related]
20. Hypothalamic-pituitary-adrenal axis suppression in systemic glucocorticoid-treated infantile hemangiomas: putting the risk into context.
Sidbury R
Arch Dermatol; 2009 Mar; 145(3):319-20. PubMed ID: 19289767
[No Abstract] [Full Text] [Related]
[Next] [New Search]
